{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:49:01Z","timestamp":1789422541320,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.gastrohep.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:41:01Z","timestamp":1653046861000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Influencia del tratamiento biol\u00f3gico en los factores de riesgo cardiovascular de los pacientes con enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"46","author":[{"given":"Clara","family":"Amiama Roig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Su\u00e1rez Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Rueda Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Poza Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-Azofra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00edn Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gonz\u00e1lez D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Amor Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00edn-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2022.05.010_bib0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohn's Colitis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: A systematic review","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10238-020-00639-y","article-title":"The risk of cardiovascular complications in inflammatory bowel disease","volume":"20","author":"Czubkowski","year":"2020","journal-title":"Clin Exp Med [Internet]."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015","article-title":"Increased risk of acute arterial events in young patients and severely active IBD: A nationwide French cohort study","volume":"67","author":"Kirchgesner","year":"2018","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0155","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: Mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2036.2008.03886.x","article-title":"Plasma lipids and inflammation in active inflammatory bowel diseases","volume":"29","author":"Romanato","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?","volume":"30","author":"Bigeh","year":"2020","journal-title":"Trends Cardiovasc Med [Internet]."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0185","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","article-title":"The increasing weight of Crohn's disease subjects in clinical trials: A hypothesis-generatings time-trend analysis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0190","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/MIB.0b013e31829cf401","article-title":"Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease","volume":"19","author":"Harper","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0195","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: A population-based cohort study","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/jcm8030343","article-title":"Increased risk of diabetes in inflammatory bowel disease patients: A nationwide population-based study in Korea","volume":"8","author":"Ae Kang","year":"2019","journal-title":"J Clin Med."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur","year":"2011","journal-title":"Am J Gastroenterol [Internet]."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gutjnl-2019-318932","article-title":"Risk of acute arterial events associated with treatment of inflammatory bowel diseases: Nationwide French cohort study","volume":"69","author":"Kirchgesner","year":"2020","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0215","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamadermatol.2020.2977","article-title":"Association between early severe cardiovascular events and the initiation of treatment with the anti-interleukin 12\/23p40 antibody ustekinumab","volume":"156","author":"Poizeau","year":"2020","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0220","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/bjd.14964","article-title":"Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: Systematic review and meta-analysis of randomized controlled trials","volume":"176","author":"Rungapiromnan","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0225","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamadermatol.2019.0001","article-title":"Association of ustekinumab vs TNF inhibitor therapy with risk of atrial fibrillation and cardiovascular events in patients with psoriasis or psoriatic arthritis","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.gastrohep.2022.05.010_bib0230","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052200156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057052200156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:45:54Z","timestamp":1759322754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057052200156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S021057052200156X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.05.010","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influencia del tratamiento biol\u00f3gico en los factores de riesgo cardiovascular de los pacientes con enfermedad inflamatoria intestinal","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}